Heart BMJ

JANUARY 29, 2025

Methods Using the publicly accessible Centers for Medicare and Medicaid Services Medicare Part D database and the Open Payments Database, this study assessed associations between industry-sponsored meal payments to physician prescribers and total amounts of Medicare claims and spending for sacubitril/valsartan between 2015 and 2021.

Medicare 52

Medicare Medicaid Heart Failure 52

GEMMS

APRIL 8, 2024

Established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) , the MIPS Program is pivotal in determining Medicare payment adjustments for healthcare practices. What is MIPS?

Medicare 52

Medicare Innovation Medicaid Patient Care 52

Stroke Journal

FEBRUARY 1, 2024

The objective of our analysis was to determine if SDOH are associated with ambulatory status at discharge following acute ischemic stroke(IS) hospitalization.Methods:We included IS patients hospitalized from January 1, 2015-December 31, 2019 who were ambulating at baseline and had known county of residence in the GWTG registry.

Stroke 40

Stroke Strokes Education Medicaid 40

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The 2024 payment adjustment is important to compensation for Medicaid services provided. EHR technology certified to the 2015 Cures Update must be in place by October 3, 2023.

Medicare 52

Medicare CMS Document Technology 52

Circulation: Cardiovascular Quality & Outcomes

MARCH 5, 2024

In 2020, patients had higher odds of initiating LAAO use than in 2015 (0.52 0.68]) versus White race, and Medicaid eligibility (aOR, 0.61 [95% CI, 0.58–0.64]) versus 9.32%; adjusted odds ratio [aOR], 13.64 [95% CI, 12.56–14.81]). Old age (ie, >85 versus 65–75 years; aOR, 0.84 [95% CI, 0.80–0.88]),

Atrial Fibrillation 40

Atrial Fibrillation Medicaid Cancer Medicare 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We examined the demographic and clinical correlates of EVT use in CVT and assessed its impact on patient outcomes utilizing a national database.MethodsWe identified CVT cases from 2015 to 2020 in the National Inpatient Sample, with EVT as the primary exposure. Individuals with Medicare (OR: 0.39, 95% CI: 0.26‐0.59, p<0.001).ConclusionWe

Thrombosis 40

Thrombosis Cancer Inpatient Hospital 40